Navigation Links
King Pharmaceuticals and Acura Pharmaceuticals Enter Agreement to Develop and Commercialize Immediate Release Pain Medicines Utilizing Acura's Aversion(R) (Abuse-Deterrent) Technology
Date:10/31/2007

nd Drug Administration ("FDA") or Acura's demonstration of certain stability and pharmacokinetic characteristics for each future product. All products developed pursuant to the Agreement will be manufactured by King or a third party contract manufacturer under the direction of King. Subject to the Agreement, King will have final decision making authority with respect to all development and commercialization activities for all products licensed.

The Agreement closing is subject to antitrust review under the Hart-Scott- Rodino Antitrust Improvements Act.

The United States Patent and Trademark Office has granted U.S. Patent No. 7,201,920 relating to Acura's Aversion(R) (abuse-deterrent) Technology, which expires on March 16, 2025.

About ACUROX(TM) Tablets

ACUROX(TM) (formerly OxyADF) is an orally administered immediate release tablet containing oxycodone HCl as an active analgesic ingredient, niacin as an active ingredient in subtherapeutic amounts, and a unique combination of other ingredients. ACUROX(TM) Tablets are intended to effectively treat moderate to moderately severe pain while discouraging the three most common methods of prescription drug abuse including (i) intravenous injection of dissolved tablets, (ii) nasal snorting of crushed tablets and (iii) intentional swallowing of excessive numbers of tablets.

Earlier this year, Acura reached agreement with the FDA on a Special Protocol Assessment for a pivotal Phase 3 clinical trial evaluating ACUROX(TM) Tablets. This clinical trial is a randomized, double-blind, placebo- controlled, multi-center, repeat-dose study evaluating the safety and efficacy of ACUROX(TM) Tablets for the treatment of acute, moderate to moderately severe postoperative pain. The 3-arm clinical trial compares two dose levels of ACUROX(TM) Tablets to placebo and is targeted to enroll 135 patients per arm (approximately 405 patients in total). Study medication will be administered to patients every six hours for
'/>"/>

SOURCE King Pharmaceuticals, Inc.; Acura Pharmaceuticals, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine news :

1. Supply of Radiopharmaceuticals Hampered by Attacks
2. FDA approves Watson Pharmaceuticals Oxytrol patch
3. Ranbaxy Pharmaceuticals Inc awarded the prestigious outstanding supplier award received from Wal-Mart
4. Antigenics Pharmaceuticals plans for Phase III trial of its Melanoma vaccine
5. United Kingdom Is Lagging In Novelty In The Field Of Pharmaceuticals
6. Top Pharmaceuticals Influence Doctors Prescriptions
7. More Study On Side Effects of ADHD Drug Needed: Shire Pharmaceuticals
8. Personalized Medicine and Innovative Pharmaceuticals
9. New lease of life for asthmatics by Accentia Biopharmaceuticals
10. Pravastatin Launched by Watson Pharmaceuticals
11. Tata Industries picks up stake in Indigene Pharmaceuticals
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... Co founders Greenlee and James Chapko, DDS have launched ... immediately deliver fully integrated dental implant services to their patients. ... surgeon. , The Center, whose name is ImplantWide, ... placing dental implants. These 6 roadblocks can discourage any ... placement of dental implants into his or her practice. ...
(Date:5/22/2015)... 22, 2015 Puritan Medical Products, ... the medical, diagnostic, environmental, and forensics industries celebrates ... products in the US. At a time when ... the US, Puritan remains committed to designing and ... Guilford, Maine facility. , Since 1919, Puritan has ...
(Date:5/22/2015)... WI (PRWEB) May 22, 2015 ... honor to be recognized for providing the highest quality ... foundation of health care decision-making,” said Javon R. Bea, ... demonstrates the commitment of our employee/partners to care for ... patients.” , Hospitals do not apply for this award, ...
(Date:5/21/2015)... York, New York (PRWEB) May 21, 2015 ... distributor of patented products, launches the Troll Motor Guide, ... convenient way of boating. , "The recreational boating industry ... Scott J. Cooper, CEO and Creative Director of ... water in record numbers and predicts continued steady growth ...
(Date:5/21/2015)... 2015 Absolute Exhibits, a trade ... state-of-the-art website that is filled with essential exhibiting tools ... information. With its original and inventive design ideas, it ... website shows hundred of pictures of client- owned or ... is not an exhibit rendering site, rather real-time pictures ...
Breaking Medicine News(10 mins):Health News:First of Its Kind Dental Implant Training and Surgicenter to Open in June 2Health News:Maine Swab Company Celebrates 96 Years of American-made Products 2Health News:Mercy Hospital and Trauma Center Receives Women’s Choice Award for Emergency Care - Mercy Health System Javon Bea 2Health News:Great Ways To Celebrate On Memorial Day Weekend- Starting With World Patent Marketing's New Boat Patent 2Health News:Great Ways To Celebrate On Memorial Day Weekend- Starting With World Patent Marketing's New Boat Patent 3Health News:New Convention and City Travel Guides Within the Absolute Exhibits’ Website 2
... (Feb. 2, 2012) Different kinds of lung cancer ... diseases. According to a University of Colorado Cancer Center ... of the American Cancer Society, different subgroups of non-small ... in the body. The study looked at ...
... By Kathleen Doheny HealthDay Reporter , THURSDAY, Feb. ... tend to eat as much or as little as their dining ... finds that women who share a meal with women they have ... at the same time. "The aim of our study was ...
... of a multicenter study coordinated by researchers at ... investigational urine-based biomarkers are associated with prostate cancers ... life-threatening among men who take a "watchful waiting," ... these markers may lead to the development of ...
... HealthDay Reporter , THURSDAY, Feb. 2 (HealthDay News) -- The ... part in determining your stroke risk, new research suggests. ... for us, in terms of skin cancer for example," noted ... the University of Alabama at Birmingham. "But this examination of ...
... A new study published in the journal Pharmacoepidemiology ... prescription statins directly to consumers are widespread, and that ... public contain very poor levels of information relevant to ... led by Professor David Brown, School of Pharmacy and ...
... High levels of a personality trait called harm avoidance -- ... associated with a higher stroke risk, a new study indicates. ... rated on the 35-item Harm Avoidance Scale. During 3-1/2 years ... percent underwent a brain autopsy. People who scored high ...
Cached Medicine News:Health News:New research confirms need for lung cancer testing 2Health News:If Your Dining Partner Overeats, So May You 2Health News:If Your Dining Partner Overeats, So May You 3Health News:Investigational urine test can predict high-risk prostate cancer in men who chose 'watchful waiting' 2Health News:Lack of Sunlight May Raise Stroke Risk 2
(Date:5/21/2015)... May 21, 2015  Cardica, Inc. (Nasdaq: CRDC ) ... Greg Watson , the company,s vice president of operations, was ... common stock, at a per share exercise price of $0.43, ... option was granted pursuant to Cardica, Inc.,s Inducement Plan, which ... 2015 under Rule 5653(c)(4) of the Nasdaq Global Market for ...
(Date:5/21/2015)... -- Heidrick & Struggles (Nasdaq: HSII ), the premier ... and culture shaping worldwide, strengthens its ... the addition of Tim Dietlin to the ... Dietlin has extensive life sciences and professional services ... and Commercial functions to increase productivity, drive transformational change, ...
(Date:5/21/2015)... Fla. , May 21, 2015 Bankers Healthcare ... is publishing a new blog series from medical writer ... The series will analyze the decision making process, ... and provide insight as to how healthcare practitioners can make ... the series was published May 7, 2015: " Being More ...
Breaking Medicine Technology:Cardica Announces New Employment Inducement Grant 2Heidrick Increases Healthcare and Life Sciences Expertise 2Medical Writer Dr. Pat Bass Publishes A New Series On The Bankers Healthcare Group BHG360 Blog 2Medical Writer Dr. Pat Bass Publishes A New Series On The Bankers Healthcare Group BHG360 Blog 3
... R.I., Nov. 2, 2010 CVS Caremark reiterated the ... (FDA) implement regulations necessary to approve biogeneric drugs under ... of Specialty Pharmacy Operations, Scott Reid, testified before the ... development of an approval pathway for biosimilar and interchangeable ...
... cancer treatments across India will become more widely available ... (NYSE: VAR ) medical linear accelerators by ... groups. Three TrueBeam™ STx systems and a UNIQUE™ accelerator ... Chennai, Mumbai and Hyderabad in 2011. "This ...
Cached Medicine Technology:CVS Caremark Reiterates Support for FDA Implementation of Approval Pathway for Biogeneric Drugs 2Varian Medical Systems to Supply Four Advanced Radiotherapy Treatment Machines to Global Hospitals in India 2Varian Medical Systems to Supply Four Advanced Radiotherapy Treatment Machines to Global Hospitals in India 3
... the easiest test to use on the market. ... no hands-on time. Critical care instructions can be ... the pediatrician's office. Valuable information can be obtained ... Now the focus can be on the results ...
The QuickScreen Pro Multi Drug Screening Test is a rapid, self-timing, qualitative immunoassay for,the detection of drugs of abuse in urine....
... qualitative immunoassays for detecting elevated levels of Luteinizing ... and results are easy to interpret. If ... the control band, then ovulation will probably occur ... test band does not appear or is lighter ...
Detect LH surge for predicting ovulation, Able to detect as low as 40 mIU/mL LH or 30 mIU/mL LH, Simple, easy and accurate, Built-in control system...
Medicine Products: